colforsin has been researched along with Endocrine Gland Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kagimoto, S; Kubota, A; Seino, S; Seino, Y; Yamada, Y | 1 |
| Chae, HD; Chung, JH; Kim, KT; Suh, BC | 1 |
| Beinfeld, MC; Vishnuvardhan, D | 1 |
3 other study(ies) available for colforsin and Endocrine Gland Neoplasms
| Article | Year |
|---|---|
Effector coupling of somatostatin receptor subtypes on human endocrine tumors.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; CHO Cells; Colforsin; Cricetinae; Cyclic AMP; Endocrine Gland Neoplasms; GTP-Binding Proteins; Humans; Pertussis Toxin; Receptors, Somatostatin; Somatostatin; Virulence Factors, Bordetella | 1996 |
Pharmacological characterization of beta2-adrenoceptor in PGT-beta mouse pineal gland tumour cells.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arylamine N-Acetyltransferase; Calcium; Colforsin; Cyclic AMP; Cytosol; Dose-Response Relationship, Drug; Drug Synergism; Endocrine Gland Neoplasms; Enzyme Activation; Epinephrine; Ethanolamines; Mice; Norepinephrine; Pineal Gland; Propanolamines; Receptors, Adrenergic, beta-2; Tumor Cells, Cultured | 1999 |
Lovastatin is a potent inhibitor of cholecystokinin secretion in endocrine tumor cells in culture.
Topics: Animals; Colforsin; Endocrine Gland Neoplasms; Lovastatin; Mevalonic Acid; Mice; Rats; Sincalide; Tumor Cells, Cultured | 2000 |